| 摘要 |
<p>This invention relates to the use of certain salts of medetomidine and its optically active enantiomers, particularly its d-enantiomer to regulate the rate of the transdermal administration of the drugs. Lipophilic salts combined with hydrophilic vehicles or hydrophilic salts combined with lipophilic vehicles exhibit good permeation.</p> |
